(163 days)
The Uritek TC-201 Urine Chemistry Test System consists of the Uritek TC-201 Urine Chemistry Analyzer and the Teco Diagnostics Urine Reagent (URS-10) Strips. The Uritek TC-201 urine analyzer is an automated, bench top instrument which is intended for point-of-care, in vitro diagnostic use only and is intended to be used together with the Teco Diagnostics Urine Reagent (URS-10) Strips as a system for semi-quantitative detection of Glucose, Bilirubin, Ketone, Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite and Leukocytes in urine. These measurements are used to aid in the diagnosis of metabolic disorders, kidney function anomalies, urinary tract infections and liver function.
The Uritek TC-201 Urine Analyzer (TC-201) is a portable easy to use instrument which reads Teco Diagnostics' Urine Reagent (URS-10) Strips for testing in the clinical laboratory. The analyzer can determine the intensity of different colors on the reagent strip test area. It does this by irradiating the test area with light and detecting the reflectance of different wavelengths using photodiode. Results are calculated by a reflection rate which is a percentage of the total reflectance of the testing wavelength and are printed automatically. The Uritek TC-201 Urine Analyzer reports semi-quantitative assays for Glucose, Bilirubin, Ketone, Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite and Leukocytes in urine. The analyzer features a display, internal printer, a serial computer interface and an electrical outlet. Communication between the operator and the analyzer is made through the display using the user interface touch screen on the front surface of the instrument. Reagent strip results are automatically displayed on the screen in one minute. A printed hardcopy can also be created either from the results screen or recalled from memory. The Urine Reagent Strips (URS-10) for Urinalysis are firm plastic strips to which ten different reagent pads are affixed. The reagent pad areas are bibulous material saturated with chemically active substances, then dried and affixed to the plastic strip with double-sided adhesive. The Teco Urine Reagent (URS-10) Strips provide tests for the semi-quantitative determination of Glucose, Bilirubin, Ketone, Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite, and Leukocytes in urine.
Here's a breakdown of the acceptance criteria and the study results for the Uritek TC-201 Urine Chemistry Test System, based on the provided document:
Acceptance Criteria and Reported Device Performance
The acceptance criterion for most analytes in the precision studies (both in-house and Point-of-Care) was 100% agreement within ±1 color block. For the comparative studies, the acceptance criteria were also based on agreement within and outside of specified color blocks. For Specific Gravity, the acceptance criteria was +/- 0.005.
Here's a summary table combining the reported performance from various studies:
| Analyte | Study Type | Acceptance Criteria | Reported Device Performance (Agreement within ±1 color block) | Reported Device Performance (Exact Match Agreement) | Sample Size (N) |
|---|---|---|---|---|---|
| Glucose | In-House Precision (L1/L2/L3) | 100% within ±1 color block | 100% (180/180) / 100% (180/180) / 100% (180/180) | 98.33% / 99.44% / 100% | 180 (each level) |
| Run-to-Run Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 100% / 100% | 120 (each level) | |
| POC Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 100% / 100% | 120 (each level) | |
| Method Comparison | 100% within ±1 color block | 100% (509/509) | 98.43% (501/509) | 509 | |
| Bilirubin | In-House Precision (L1/L2/L3) | 100% within ±1 color block | 100% (180/180) / 100% (180/180) / 100% (180/180) | 98.33% / 100% / 100% | 180 (each level) |
| Run-to-Run Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 99.17% / 100% / 100% | 120 (each level) | |
| POC Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 99.17% / 100% | 120 (each level) | |
| Method Comparison | 100% within ±1 color block | 100% (509/509) | 98.82% (503/509) | 509 | |
| Ketone | In-House Precision (L1/L2/L3) | 100% within ±1 color block | 100% (180/180) / 100% (180/180) / 100% (180/180) | 99.44% / 100% / 100% | 180 (each level) |
| Run-to-Run Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 100% / 100% | 120 (each level) | |
| POC Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 100% / 100% | 120 (each level) | |
| Method Comparison | 100% within ±1 color block | 100% (509/509) | 98.43% (501/509) | 509 | |
| Specific Gravity | In-House Precision (L1/L2/L3) | 100% within ±1 color block; +/- 0.005 | 100% (180/180) / 100% (180/180) / 100% (180/180) | 97.78% / 98.89% / 99.44% | 180 (each level) |
| Run-to-Run Precision (L1/L2/L3) | 100% within ±1 color block; +/- 0.005 | 100% (120/120) / 100% (120/120) / 100% (120/120) | 98.33% / 97.50% / 100% | 120 (each level) | |
| POC Precision (L1/L2/L3) | 100% within ±1 color block; +/- 0.005 | 100% (120/120) / 100% (120/120) / 100% (120/120) | 99.17% / 100% / 100% | 120 (each level) | |
| Method Comparison | 100% within ±1 color block; +/- 0.005 | 100% (509/509) | 82.71% (421/509) | 509 | |
| Blood | In-House Precision (L1/L2/L3) | 100% within ±1 color block | 100% (180/180) / 100% (180/180) / 100% (180/180) | 100% / 100% / 100% | 180 (each level) |
| Run-to-Run Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 100% / 100% | 120 (each level) | |
| POC Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 99.17% / 100% | 120 (each level) | |
| Method Comparison | 100% within ±1 color block | 100% (509/509) | 98.04% (499/509) | 509 | |
| Nitrite | In-House Precision (L1/L2/L3) | 100% within ±1 color block | 100% (180/180) / 100% (180/180) / 100% (180/180) | 100% / 100% / 100% | 180 (each level) |
| Run-to-Run Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 100% / 100% | 120 (each level) | |
| POC Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 100% / 100% | 120 (each level) | |
| Method Comparison | N/A (not applicable for ±1 color block) | N/A | 99.41% (506/509) | 509 | |
| Protein | In-House Precision (L1/L2/L3) | 100% within ±1 color block | 100% (180/180) / 100% (180/180) / 100% (180/180) | 100% / 99.44% / 100% | 180 (each level) |
| Run-to-Run Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 99.17% / 100% | 120 (each level) | |
| POC Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 100% / 100% | 120 (each level) | |
| Method Comparison | 100% within ±1 color block | 100% (509/509) | 97.25% (495/509) | 509 | |
| Urobilinogen | In-House Precision (L1/L2/L3) | 100% within ±1 color block | 100% (180/180) / 100% (180/180) / 100% (180/180) | 100% / 100% / 100% | 180 (each level) |
| Run-to-Run Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 100% / 100% | 120 (each level) | |
| POC Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 99.17% / 100% / 100% | 120 (each level) | |
| Method Comparison | 100% within ±1 color block | 100% (509/509) | 99.61% (507/509) | 509 | |
| Leukocyte | In-House Precision (L1/L2/L3) | 100% within ±1 color block | 100% (180/180) / 100% (180/180) / 100% (180/180) | 100% / 98.89% / 100% | 180 (each level) |
| Run-to-Run Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 100% / 100% | 120 (each level) | |
| POC Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 100% / 99.17% / 100% | 120 (each level) | |
| Method Comparison | 100% within ±1 color block | 100% (509/509) | 97.84% (498/509) | 509 | |
| pH | In-House Precision (L1/L2/L3) | 100% within ±1 color block | 100% (180/180) / 100% (180/180) / 100% (180/180) | 96.11% / 99.44% / 98.89% | 180 (each level) |
| Run-to-Run Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 97.50% / 99.17% / 100% | 120 (each level) | |
| POC Precision (L1/L2/L3) | 100% within ±1 color block | 100% (120/120) / 100% (120/120) / 100% (120/120) | 98.33% / 98.33% / 100% | 120 (each level) | |
| Method Comparison | 100% within ±1 color block | 99.61% (507/509) | 90.57% (461/509) | 509 |
Note: "L1", "L2", "L3" refer to Level I (High), Level II (Low), and Level III (Negative/Trace) control solutions, respectively. "N" indicates the number of tests performed.
Additional Information:
2. Sample size used for the test set and the data provenance:
- Precision Studies (In-house):
- Within-Run: 180 strips per control level (20 strips x 3 strip lots x 1 day x 3operators/analyzers).
- Run-to-Run: 120 strips per control level (3 strips x 2 runs x 10 days x 2 operators/analyzers/strip lots).
- Data Provenance: In-house studies using commercially available urine control solutions. The country of origin of the data is not explicitly stated but implied to be from the manufacturer's facility.
- Precision Studies (Point-of-Care):
- Sample Size: 40 tests per sample (duplicates per run, two runs per day for 10 days). Combined across 3 POC sites, the total for each control level (L1, L2, L3) was 120 (40 tests x 3 sites).
- Data Provenance: Prospective, from three Point-of-Care (POC) sites: Clinica Medica Del Sagrado Corazon (Anaheim, CA), Clinica Medica San Miquel (Santa Ana, CA), and Artritis & Osteoporosis Center (Edinburg, TX). This data is from the USA.
- Method Comparison Study:
- Sample Size: A total of 509 urine specimens. This comprised:
- At least 115 unaltered patient samples per site from 3 POC sites (total > 345).
- Additional contrived samples (10% of total samples).
- 91 clinical samples from POC Site I and Site II.
- A separate study at Site I with 26 patient urine samples prescreened at pH ≥ 8.0.
- Data Provenance: Prospective, from three Point-of-Care (POC) sites in the USA. Samples were a mix of unaltered patient samples and contrived samples.
- Sample Size: A total of 509 urine specimens. This comprised:
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Precision Studies: Ground truth was established by the expected ranges of commercially available urine control solutions (HYCOR Biomedical), which have known target analyte concentrations confirmed by their package inserts and certificates of analysis. No external human experts are explicitly mentioned for these studies beyond the internal operators.
- Method Comparison Study: The ground truth for the method comparison study was established by the predicate device, the Siemens Clinitek Status+ Urine Analyzer (using Clinitek Multistix 10 SG Strips). This is a comparison between two devices, not a comparison against a clinical expert consensus or pathology.
- Linearity/Assay Reportable Range: For pH, a pH meter was used to confirm results. For specific gravity, a clinical, handheld refractometer was used. These serve as the "ground truth" or reference methods for these specific parameters. Three operators performed these measurements.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
- Adjudication Method: Not explicitly described in the provided text for most studies. The precision studies rely on the expected values of control solutions. The method comparison study compares the Uritek TC-201 directly against the predicate device; discrepancies are noted but a formal multi-expert adjudication process is not detailed. For the precision studies, results were considered "within the expected results +/- one color block"; however, the process for resolving disagreements or establishing a definitive ground truth in cases of initial disagreement is not specified beyond relying on the control solution's stated values.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- This document describes a clinical chemistry test system for urine analysis, which is an automated instrument reading reagent strips. It is not an AI-assisted diagnostic imaging or human-in-the-loop system. Therefore, an MRMC comparative effectiveness study involving human readers and AI assistance is not applicable and was not performed.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- The Uritek TC-201 Urine Analyzer is described as an automated, bench top instrument that "reads Teco Diagnostics' Urine Reagent (URS-10) Strips". It operates by "irradiating the test area with light and detecting the reflectance of different wavelengths using photodiode" and "Results are calculated by a reflection rate... and are printed automatically." This indicates that the device operates in a standalone (algorithm only) manner for interpreting the reagent strips. Human involvement is primarily in sample preparation and loading, and interpreting the printed results.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- Precision Studies: Ground truth was established by the expected ranges of commercially available urine control solutions with confirmed analyte concentrations.
- Linearity/Assay Reportable Range Study: For pH, a pH meter was the ground truth. For Specific Gravity, a clinical, handheld refractometer was the ground truth.
- Method Comparison Study: The ground truth was the predicate device's measurements (Siemens Clinitek Status+ Urine Analyzer).
8. The sample size for the training set:
- The document describes performance testing for a diagnostic device, not the development or training of a machine learning model. Therefore, a "training set" in the context of AI/ML is not applicable here. The studies described are for verification and validation of the device's analytical performance against established standards and a predicate device.
9. How the ground truth for the training set was established:
- As mentioned above, there is no "training set" in the context of AI/ML for this device. The ground truth for the various performance studies (precision, linearity, method comparison) was established using commercially available control solutions with known values, reference instruments (pH meter, refractometer), and comparison to a legally marketed predicate device.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with a triple-lined design representing the bodies.
July 22, 2016
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
TECO DIAGNOSTICS, INC. AQUIL MERCHANT RESEARCH SCIENTIST 1268 N. LAKEVIEW AVE. ANAHEIM CA 92807
Re: K160372
Trade/Device Name: Uritek TC-201 Urine Chemistry Test System Regulation Number: 21 CFR 862.1340 Regulation Name: Urinary glucose (nonquantitative) test system Regulatory Class: II Product Code: JIL, JIO, KQO, LJX, JRE, CEN, JMT, JIR, JIN, CDM, JJB Dated: June 1, 2016 Received: June 2, 2016
Dear Mr. Merchant:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{1}------------------------------------------------
If you desire specific advice for your device on our labeling regulations (21 CFR Parts 801 and 809), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Katherine Serrano -S
For :
Courtney H. Lias, Ph.D. Director Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
| DEPARTMENT OF HEALTH AND HUMAN SERVICES | |
|---|---|
| Food and Drug Administration | |
| Indications for Use | |
| Form Approved: OMB No. 0910-0120 | |
| Expiration Date: January 31, 2017 | |
| See PRA Statement below. | |
| 510(k) Number (if known) | K160372 |
| Device Name | Uritek TC-201 Urine Chemistry Test System |
| Indications for Use (Describe) | The Uritek TC-201 Urine Chemistry Test System consists of the Uritek TC-201 Urine Chemistry Analyzer and the Teco Diagnostics Urine Reagent (URS-10) Strips. The Uritek TC-201 urine analyzer is an automated, bench top instrument which is intended for point-of-care, in vitro diagnostic use only and is intended to be used together with the Teco Diagnostics Urine Reagent (URS-10) Strips as a system for semi-quantitative detection of Glucose, Bilirubin, Ketone, Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite and Leukocytes in urine. These measurements are used to aid in the diagnosis of metabolic disorders, kidney function anomalies, urinary tract infections and liver function. |
| Type of Use (Select one or both, as applicable) | |
| Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) | |
| CONTINUE ON A SEPARATE PAGE IF NEEDED. | |
| This section applies only to requirements of the Paperwork Reduction Act of 1995. | |
| DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW. | |
| The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: | |
| Department of Health and Human Services | |
| Food and Drug Administration | |
| Office of Chief Information Officer | |
| Paperwork Reduction Act (PRA) Staff | |
| PRAStaff@fda.hhs.gov | |
| "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." | |
| FORM FDA 3881 (8/14) | Page 1 of 1 PSC Publishing Services (301) 443-6740 EF |
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
I. SUBMITTER
Applicant Information:
Teco Diagnostics, Inc. 1268 North Lakeview Avenue Anaheim, CA 92807 Phone: 714-463-1111 Fax: 714-463-1169
Contact Person: Aquil Merchant, M.S. Research Scientist Email: aquil@tecodiagnostics.com | Web: http://www.tecodiagnostics.com
Date Prepared: July 20th, 2016
II. DEVICE
Device Name: Uritek TC-201 Urine Chemistry Test System
Common Name:
Automated Urinalysis System, Urinary Test System The system consists of the Uritek TC-201 Urine Analyzer and the Teco Diagnostics Urine Reagent (URS-10) Strips (K970250).
Regulatory Information:
Panel:
Clinical Chemistry
| Regulation section | Code | Test | Classification |
|---|---|---|---|
| 21 CFR § 862.1340 | JIL | Urinary Glucose (nonquantitative) Test System | II |
| 21 CFR § 864.6550 | JIO | Occult Blood Test | II |
| 21 CFR § 862.2900 | KQO | Automated Urinalysis System | I |
| 21 CFR § 864.7675 | LJX | Leukocyte Peroxidase Test | I |
| 21 CFR § 862.2800 | JRE | Refractometer for clinical use | I |
| 21 CFR § 862.1550 | CEN | Urinary pH (nonquantitative) Test System | I |
| 21 CFR § 862.1510 | JMT | Nitrite (nonquantitative) Test System | I |
| 21 CFR § 862.1645 | JIR | Urinary Protein or Albumin (nonquantitative) Test System | I |
{4}------------------------------------------------
Image /page/4/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
| 21 CFR § 862.1435 | JIN | Ketones (nonquantitative) Test System | I |
|---|---|---|---|
| 21 CFR § 862.1785 | CDM | Urinary Urobilinogen (nonquantitative) Test System | I |
| 21 CFR § 862.1115 | JJB | Urinary Bilirubin and its conjugates (nonquantitative) Test System | I |
III. PREDICATE DEVICE
Siemens (formally Bayer) Clinitek Status Plus Analyzer SIEMENS HEALTHCARE DIAGNOSTICS 2 Edgewater Dr. Norwood, MA 02062 510(k) Number: K091216
IV. DEVICE DESCRIPTION
The Uritek TC-201 Urine Analyzer (TC-201) is a portable easy to use instrument which reads Teco Diagnostics' Urine Reagent (URS-10) Strips for testing in the clinical laboratory. The analyzer can determine the intensity of different colors on the reagent strip test area. It does this by irradiating the test area with light and detecting the reflectance of different wavelengths using photodiode. Results are calculated by a reflection rate which is a percentage of the total reflectance of the testing wavelength and are printed automatically.
The Uritek TC-201 Urine Analyzer reports semi-quantitative assays for Glucose, Bilirubin, Ketone, Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite and Leukocytes in urine. The analyzer features a display, internal printer, a serial computer interface and an electrical outlet. Communication between the operator and the analyzer is made through the display using the user interface touch screen on the front surface of the instrument. Reagent strip results are automatically displayed on the screen in one minute. A printed hardcopy can also be created either from the results screen or recalled from memory.
The Urine Reagent Strips (URS-10) for Urinalysis are firm plastic strips to which ten different reagent pads are affixed. The reagent pad areas are bibulous material saturated with chemically active substances, then dried and affixed to the plastic strip with double-sided adhesive. The Teco Urine Reagent (URS-10) Strips provide tests for the semi-quantitative determination of Glucose, Bilirubin, Ketone, Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite, and Leukocytes in urine.
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in a simple, sans-serif font.
V. INDICATIONS FOR USE
The Uritek TC-201 Urine Chemistry Test System consists of the Uritek TC-201 Urine Chemistry Analyzer and the Teco Diagnostics Urine Reagent (URS-10) Strips. The Uritek TC-201 urine analyzer is an automated, bench top instrument which is intended for point-of-care, in vitro diagnostic use only and is intended to be used together with the Teco Diagnostics Urine Reagent (URS-10) Strips as a system for semi-quantitative detection of Glucose, Bilirubin, Ketone, Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite and Leukocytes in urine. These measurements are used to aid in the diagnosis of metabolic disorders, kidney function anomalies, urinary tract infections and liver function.
VI. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICE
The Uritek TC-201 Urine Analyzer and the Clinitek Status Plus Analyzer, a POC device currently sold in the US market, share the same technological characteristics including the analytical method, testing parameters, calibration method, and power requirements. They only differ in battery, language option, their memory size, dimensions and weight. The comparison is summarized in the following table:
| Proposed Device | Predicate | ||
|---|---|---|---|
| Trade Name | Uritek TC-201 Urine Analyzer | Clinitek Status Plus Urine Analyzer | |
| Intended Use | The device is intended to be used together with the Teco Diagnostics Urine Reagent (URS-10) Strips as a system for the semi-quantitative detection of Glucose, Bilirubin, Ketone, Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite, and Leukocytes in urine. | The device is intended to be used together with Clinitek Multistix 10 SG Strips as a system for the semi-quantitative detection of Glucose, Bilirubin, Ketone, Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite, and Leukocytes in urine. | |
| Methodology | Reflectance Photometer | Reflectance Photometer | |
| Specimen Type | Urine | Same | |
| Chemistry Strips | Teco Diagnostics Urine Reagent (URS-10) Strips | Clinitek Multistix 10 SG | |
| AnalyticalMethod | The analyzer measures theintensity of the light reflected fromthe reagent pads of a urinalysis | Same | |
| TestingParameters | Glucose, Bilirubin, Ketone,Specific Gravity, Blood, pH,Protein, Urobilinogen, Nitrite, andLeukocytes | Glucose, Bilirubin, Ketone,Specific Gravity, Blood, pH,Protein, Urobilinogen, Nitrite,and Leukocytes | |
| CalibrationMethod | Self-calibration with the whitereflective check area located at theback of the test strip bed | Same | |
| Operatinginterface | Touch Screen | Same | |
| EnteredParameter | Urine Color and Clarity, PatientID and Operator ID | Same | |
| Printer | Built-in thermal printer | Same | |
| PC Port | Standard RS232 Serial Port,USB Port | Same | |
| Power | Input 100-240 VAC ± 20% and45-65Hz, output + 9V | Same | |
| Battery PoweredOperation | None | 6 AA non-rechargeable alkalinebatteries | |
| Line LeakageCurrent | <0.5mA | <0.5mA | |
| AnalyzerOperatingConditions | 18-30°C (64-86°F); 18%-80%Relative Humidity (non-condensing) | Same | |
| Memory | Store up to 2000 test results | Store up to 950 test results | |
| Display Language | English, Spanish, Chinese | English, Spanish | |
| Screen Display | Color | Mono-tone | |
| Dimensions | Width 7.25 inDepth 10.5 inHeight 6.5 in | Width 6.7 inDepth 10.7 inHeight 6.2 in | |
| Weight | 1.88kg (4.14 lbs) | 1.66kg (3.65 lbs) |
{6}------------------------------------------------
Image /page/6/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
1268 N. Lakeview Ave., Anaheim, CA 92807, U.S.A. Phone: (714) 463-1111 Toll Free: 1-800-222-9880 Fax: (714) 463-1169 www.tecodiagnostics.com
510(k) SUMMARY
{7}------------------------------------------------
Image /page/7/Picture/0 description: The image shows the logo for "Teco Diagnostics". The logo consists of a green hexagon with the letters "TC" in white inside the hexagon. To the right of the hexagon is the text "Teco Diagnostics" in black.
The Teco Diagnostics Urine Reagent (URS-10) Strips and Clinitek Multistix 10 SG Strips share the same characteristics including Glucose, Bilirubin, Ketone, Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite and Leukocyte methodologies.
VII TEST PRINCIPLE
Glucose: This test is based on a double sequential enzyme reaction. One enzyme, glucose oxidase, catalyzes the reaction in which glucose is oxidized to produce gluconic acid and hydrogen peroxide. A second enzyme, peroxidase, catalyzes the reaction of hydrogen peroxide with potassium iodide chromogen in which the chromogen is oxidized to different colors ranging from blue-green to greenish-brown through brown and dark brown.
Bilirubin: This test is based on the coupling of bilirubin with a diazotized dichioroaniline in a strongly acid medium. Varying bilirubin levels will produce light tan to reddish brown color proportional to its concentration in urine.
Ketone: This test is based on the reaction of acetoacetic acid with sodium nitroprusside in a strongly basic medium. The colors range from beige or buff-pink color for a "Negative" reading to pink and pink-purple for a "Positive" reading.
Specific Gravity: This test is based on the apparent pKa change of certain pretreated polyelectrolytes in relation to the ionic concentration. In the presence of an indicator, the colors range from dark blue or blue-green in urine of low ionic concentration to green and yellow-green in urine of higher ionic concentration.
Blood: This test is based on the pseudoperoxidase action of hemoglobin and erythrocytes which catalyzes the reaction of 3,3,5,5 '-tetramethyl-benzidine and buffered organic peroxide. The resulting colors range from orange to yellow-green and dark green. Very high blood concentration may cause the color development to continue to dark blue.
pH: This test is based on the well-known double pH indicator method, where bromothymol blue and methyl red give distinguishable colors over the pH range of 5-9. The colors range from redorange to yellow and yellow-green to blue-green.
Protein: This test is based on the protein error-of-indicator principle. At a constant pH, the development of any green color is due to the presence of protein. Colors range from yellow for a "Negative" reaction to yellow-green and green to blue-green for a "Positive" reaction.
Urobilinogen: This test is based on a modified Ehrlich reaction in which pdiethylaminobenzaldehyde reacts with urobilinogen in a strongly acid medium. Colors range from light pink to bright magenta.
{8}------------------------------------------------
Image /page/8/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside. To the right of the hexagon is the text "Teco Diagnostics" in black. The text is in a simple, sans-serif font.
Nitrite: This test depends on the conversion of nitrate to nitrite by the action of Gram negative bacteria in the urine. The nitrite reacts with p-arsanilic acid to from a diazonium compound in an acid medium. The diazoniumn compound in turn couples with 1,2,3,4- tetrahydrobenzo(h) quinolin to produce a pink color.
Leukocytes: This test is based on the action of esterase present in leukocytes, which catalyzes the hydrolysis of an indoxyl ester derivative. The indoxyl ester liberated reacts with a diazoniumn salt to produce a beige-pink to purple color.
{9}------------------------------------------------
Image /page/9/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside. To the right of the hexagon is the text "Teco Diagnostics" in black.
VIII. SUMMARY OF PERFORMANCE TESTING
1. Software
The software development, verification, and validation were performed according to the Food and Drug Administration's guidance document. The contents of the software testing for this submission conform to the Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices as shown in Section 16 - Software.
2. Electrical Safety and Electromagnetic Compatibility
The Uritek TC-201 Urine Analyzer device complies with the applicable voluntary standards which include IEC 61010-1, IEC 61010-2-101, IEC 61326-1 and IEC 61326-2-6 for Electromagnetic Compatibility and Safety. The Electrical Safety and EMC Report are included in the Electromagnetic Compatibility and Electrical Safety Section 17 of the submission.
3. Analytical Performance
The analytical performance of Uritek TC-201 Urine Analyzer with the Teco Diagnostics Urine Reagent (URS-10) Strips was verified by Precision Study, Sensitivity Study, Stability Study, Interference Study and Flex Study. The analytical testing and comparison testing are detailed in Performance Testing - Bench Section 18 of the submission. Below are the summaries of the testing results:
A. Precision Study:
i) In-house Precision Study:
Within Run Precision of Uritek TC-201 Urine Analyzer with the Teco Diagnostics Urine Reagent Strips (URS-10) was evaluated using commercially available urine control solutions at Level I (High analyte concentration), Level II (Low analyte concentration) and Level III (Negative). The package insert and certificate of analysis of these control solutions confirmed the specific target analyte concentration in each level. The repeatability of the Uritek TC-201 Urine Analyzer was evaluated by testing each level of control solution by three operators on three analyzers in replicates of 20 per run per day with three strip lots. A total of 180 strips were used for each level control solution tested (20 strips x 3 strip lots x 1 day x 3operators/analyzers = 180 tests per control).
As shown in the following tables, all analytes read 100% within the expected results +/- one color block. Please see Appendix 18.B for In-House Precision Study Data tables. The results from the Within-Run Precision study are summarized below:
| Analyte | Level | Exact MatchAgreement | % Agreement(Exact Match) | +/- ColorBlockAgreement | % Agreement(+/- ColorBlock) | N |
|---|---|---|---|---|---|---|
| Glucose | 1000 mg/dL | 177/180 | 98.33 | 180/180 | 100 | 180 |
Urine Control Level I
{10}------------------------------------------------
Image /page/10/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
1268 N. Lakeview Ave., Anaheim, CA 92807, U.S.A. Phone: (714) 463-1111 Toll Free: 1-800-222-9880 Fax: (714) 463-1169 www.tecodiagnostics.com
510(k) SUMMARY
| Bilirubin | Large | 177/180 | 98.33 | 180/180 | 100 | 180 |
|---|---|---|---|---|---|---|
| Ketone | 80 mg/dL | 179/180 | 99.44 | 180/180 | 100 | 180 |
| Specific Gravity | 1.015 | 176/180 | 97.78 | 180/180 | 100 | 180 |
| Blood | Large | 180/180 | 100 | 180/180 | 100 | 180 |
| Nitrite | Positive | 180/180 | 100 | 180/180 | 100 | 180 |
| Protein | 300 mg/dL | 180/180 | 100 | 180/180 | 100 | 180 |
| Urobilinogen | 8.0 EU/dL | 180/180 | 100 | 180/180 | 100 | 180 |
| Leukocyte | Large | 180/180 | 100 | 180/180 | 100 | 180 |
| pH | 8.0 | 173/180 | 96.11 | 180/180 | 100 | 180 |
Urine Control Level II
| Analyte | Level | ExactMatchAgreement | % Agreement(Exact Match) | +/- ColorBlockAgreement | % Agreement(+/- ColorBlock) | N |
|---|---|---|---|---|---|---|
| Glucose | 250 mg/dL | 179/180 | 99.44 | 180/180 | 100 | 180 |
| Bilirubin | Small | 180/180 | 100 | 180/180 | 100 | 180 |
| Ketone | 40 mg/dL | 180/180 | 100 | 180/180 | 100 | 180 |
| Specific Gravity | 1.010 | 178/180 | 98.89 | 180/180 | 100 | 180 |
| Blood | Moderate | 180/180 | 100 | 180/180 | 100 | 180 |
| Nitrite | Positive | 180/180 | 100 | 180/180 | 100 | 180 |
| Protein | Trace | 179/180 | 99.44 | 180/180 | 100 | 180 |
| Urobilinogen | 0.2 EU/dL | 180/180 | 100 | 180/180 | 100 | 180 |
| Leukocyte | Moderate | 178/180 | 98.89 | 180/180 | 100 | 180 |
| pH | 8.0 | 179/180 | 99.44 | 180/180 | 100 | 180 |
Urine Control Level III
| Analyte | Level | ExactMatchAgreement | % Agreement(Exact Match) | +/- ColorBlockAgreement | % Agreement(+/- ColorBlock) | N |
|---|---|---|---|---|---|---|
| Glucose | Negative | 180/180 | 100 | 180/180 | 100 | 180 |
| Bilirubin | Negative | 180/180 | 100 | 180/180 | 100 | 180 |
| Ketone | Negative | 180/180 | 100 | 180/180 | 100 | 180 |
| Specific Gravity | 1.010 | 179/180 | 99.44 | 180/180 | 100 | 180 |
| Blood | Negative | 180/180 | 100 | 180/180 | 100 | 180 |
| Nitrite | Negative | 180/180 | 100 | 180/180 | 100 | 180 |
{11}------------------------------------------------
Image /page/11/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside. To the right of the hexagon is the text "Teco Diagnostics" in black font. The text is slightly larger than the letters inside the hexagon.
| Protein | Negative | 180/180 | 100 | 180/180 | 100 | 180 |
|---|---|---|---|---|---|---|
| Urobilinogen | 0.2 EU/dL | 180/180 | 100 | 180/180 | 100 | 180 |
| Leukocyte | Negative | 180/180 | 100 | 180/180 | 100 | 180 |
| pH | 6.0 | 178/180 | 98.89 | 180/180 | 100 | 180 |
The Run to Run precision of Uritek TC-201 Urine Analyzer with the Teco Diagnostics Urine Reagent Strips (URS-10) was evaluated by testing each level of control solution (negative, low positive, and high positive) by two operators with three lots of URS-10 strips in three replicate assays per run, 2 non- consecutive runs each day for over 10 days on 2 Uritek TC-201 Urine Analyzer. Run 1 and Run 2 were separated by atleast 1 hour. A total of 120 strips were used for each level control solution tested (3 strips x 2 run x 10 days x 2 operators/analyzers/strip lots = 120 tests per control).
As shown in the following tables, all analytes read 100% within the expected results +/- one color block. Please see Appendix 18.B for In-House Precision Study Data tables. The results from the Run to Run Precision study are summarized below:
| Analyte | Level | Exact MatchAgreement | % Agreement(Exact Match) | +/- ColorBlockAgreement | % Agreement(+/- ColorBlock) | N |
|---|---|---|---|---|---|---|
| Glucose | 1000 mg/dL | 120/120 | 100 | 120/120 | 100 | 120 |
| Bilirubin | Large | 119/120 | 99.17 | 120/120 | 100 | 120 |
| Ketone | 80 mg/dL | 120/120 | 100 | 120/120 | 100 | 120 |
| Specific Gravity | 1.015 | 118/120 | 98.33 | 120/120 | 100 | 120 |
| Blood | Large | 120/120 | 100 | 120/120 | 100 | 120 |
| Nitrite | Positive | 120/120 | 100 | 120/120 | 100 | 120 |
| Protein | 300 mg/dL | 120/120 | 100 | 120/120 | 100 | 120 |
| Urobilinogen | 8.0 EU/dL | 120/120 | 100 | 120/120 | 100 | 120 |
| Leukocyte | Large | 120/120 | 100 | 120/120 | 100 | 120 |
| pH | 8.0 | 117/120 | 97.50 | 120/120 | 100 | 120 |
Urine Control Level I
Urine Control Level II
| Analyte | Level | ExactMatchAgreement | % Agreement(Exact Match) | +/- ColorBlockAgreement | % Agreement(+/- ColorBlock) | N |
|---|---|---|---|---|---|---|
| Glucose | 250 mg/dL | 120/120 | 100 | 120/120 | 100 | 120 |
{12}------------------------------------------------
Image /page/12/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
1268 N. Lakeview Ave., Anaheim, CA 92807, U.S.A. Phone: (714) 463-1111 Toll Free: 1-800-222-9880 Fax: (714) 463-1169 www.tecodiagnostics.com
510(k) SUMMARY
| Bilirubin | Small | 120/120 | 100 | 120/120 | 100 | 120 |
|---|---|---|---|---|---|---|
| Ketone | 40 mg/dL | 120/120 | 100 | 120/120 | 100 | 120 |
| Specific Gravity | 1.010 | 117/120 | 97.50 | 120/120 | 100 | 120 |
| Blood | Moderate | 120/120 | 100 | 120/120 | 100 | 120 |
| Nitrite | Positive | 120/120 | 100 | 120/120 | 100 | 120 |
| Protein | Trace | 119/120 | 99.17 | 120/120 | 100 | 120 |
| Urobilinogen | 0.2 EU/dL | 120/120 | 100 | 120/120 | 100 | 120 |
| Leukocyte | Moderate | 120/120 | 100 | 120/120 | 100 | 120 |
| pH | 8.0 | 119/120 | 99.17 | 120/120 | 100 | 120 |
Urine Control Level III
| Analyte | Level | ExactMatchAgreement | % Agreement(Exact Match) | +/- ColorBlockAgreement | % Agreement(+/- ColorBlock) | N |
|---|---|---|---|---|---|---|
| Glucose | Negative | 120/120 | 100 | 120/120 | 100 | 120 |
| Bilirubin | Negative | 120/120 | 100 | 120/120 | 100 | 120 |
| Ketone | Negative | 120/120 | 100 | 120/120 | 100 | 120 |
| Specific Gravity | 1.010 | 120/120 | 100 | 120/120 | 100 | 120 |
| Blood | Negative | 120/120 | 100 | 120/120 | 100 | 120 |
| Nitrite | Negative | 120/120 | 100 | 120/120 | 100 | 120 |
| Protein | Negative | 120/120 | 100 | 120/120 | 100 | 120 |
| Urobilinogen | 0.2 EU/dL | 120/120 | 100 | 120/120 | 100 | 120 |
| Leukocyte | Negative | 120/120 | 100 | 120/120 | 100 | 120 |
| pH | 6.0 | 120/120 | 100 | 120/120 | 100 | 120 |
ii) Point-of-Care Precision Study:
The precision of Uritek TC-201 Urine Analyzer at point-of-care (POC) sites was evaluated using commercially available urine control solutions at Level I (High analyte concentration), Level II (Low analyte concentration) and Level III (Negative). The package insert and certificate of analysis of these control solutions confirmed the specific target analyte concentration in each level. The three level control solutions were dispensed in to different containers and were randomly labeled with numbers. Each sample was tested in duplicates per run, two runs per day for 10 days (N = 40 testing per sample).
{13}------------------------------------------------
Image /page/13/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black font.
POC sites
Site 1: Clinica Medica Del Sagrado Corazon
831 S. Harbor Blvd. Anaheim, CA 92805 Doctor: Rouben Calatian MD
Site 2: Clinica Medica San Miquel
1306 W. Santa Ana Blvd., Santa Ana, CA 92703 Doctor: Martin Bande MD
Site 3: Artritis & Osteoporosis Center
2601 Cornerstone Blvd, Edinburg, TX 78539 Doctor: Jorge C Zamora-Quezada MD
Precision procedures provided to each POC site
Please see Appendix 18.A Precision Study Protocol for POC Sites for the detail.
Results for Point-of-Care Precision:
As shown in the following tables, all analytes read 100% within the expected results +/- one color block. Please see Appendix 18.C for Point-of-Care Run to Run Precision Data tables.
Analyte Levels Tested:
| Analyte | Target Concentration | ||
|---|---|---|---|
| Level I | Level II | Level III | |
| Glucose | 1000 mg/dL | 250 mg/dL | Negative |
| Bilirubin | Large | Small | Negative |
| Ketone | 80 mg/dL | 40 mg/dL | Negative |
| Specific Gravity | 1.015 | 1.010 | 1.010 |
| Blood | Large | Moderate | Negative |
| Nitrite | Positive | Positive | Negative |
| Protein | 300 mg/dL | Trace | Negative |
| Urobilinogen | 8.0 EU/dL | 0.2 EU/dL | 0.2 EU/dL |
| Leukocyte | Large | Moderate | Negative |
| pH | 8.0 | 8.0 | 6.0 |
{14}------------------------------------------------
Image /page/14/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
Results Summary:
Three POC sites combined:
| Analyte | Control Level I | Control Level II | Control Level III | |||
|---|---|---|---|---|---|---|
| Exact Match | Match within$\pm$ 1 color block | Exact Match | Match within$\pm$ 1 color block | Exact Match | Match within$\pm$ 1 color block | |
| Glucose | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) |
| Bilirubin | 100%(120/120) | 100%(120/120) | 99.17%(119/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) |
| Ketone | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) |
| Specific Gravity | 99.17%(119/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) |
| Blood | 100%(120/120) | 100%(120/120) | 99.17%(119/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) |
| Nitrite | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) |
| Protein | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) |
| Urobilinogen | 99.17%(119/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) |
| Leukocyte | 100%(120/120) | 100%(120/120) | 99.17%(119/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) |
| pH | 98.33%(118/120) | 100%(120/120) | 98.33%(118/120) | 100%(120/120) | 100%(120/120) | 100%(120/120) |
B. Linearity/Assay Reportable Range
A study to evaluate the reportable range for each analyte color block on the Teco Diagnostics Urine Reagent Strips (URS-10) was performed by measuring negative urine and negative urine spiked with known increasing and decreasing concentrations of analytes relative to each color block covering the entire measuring range of each analyte present on the URS-10 strip. Sample measurement was performed in replicates of 8 by 3 operators on each of 3 individual strip lots (8 strips x 3 operators/ strip lots), for a total of 24 measurements for every sample tested. A pH meter was used to confirm the pH results. The specific gravity values were confirmed by a
{15}------------------------------------------------
Image /page/15/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside the hexagon. To the right of the hexagon is the text "Teco Diagnostics" in black. The text is in a simple, sans-serif font.
clinical, handheld refractometer. Specific gravity measurements were performed in replicates of 8 by 3 operators on each of 3 individual strip lots (8 strips x 3 operators/ strip lots), for a total of 24 measurements for every sample tested.
The measuring range for each concentration color block is listed in the following table based on the results of Detection Limit Study in section 18.3. Please refer to Appendix 18.F for data tables.
Color Block Output Units Measuring Range Analyte 0.0 - 75 mg/dL Negative 75 – 212.5 mg/dL 100 mg/dL 250 mg/dL 212.5 - 437.5 mg/dL Glucose 500 mg/dL 437.5 - 875 mg/dL 1000 mg/dL > 875 mg/dL Negative 0.0 – 0.5 mg/dL Small 0.5 - 1.5 mg/dL Bilirubin Moderate 1.75 - 3.0 mg/dL Large > 3.0 mg/dL 0.0 – 3.75 mg/dL Negative Trace 3.75 - 10.0 mg/dL Ketone 15 mg/dL 10.0 — 27.5 mg/dL 40 mg/dL 27.5 – 60.0 mg/dL 80 mg/dL > 60.0 mg/dL 0 - 7.5 Ery/uL Negative 7.5 - 21.25 Ery/uL Trace Blood Small 21.25 — 52.5 Ery/μL Moderate 52.5 - 170 Ery/uL Large > 170 Ery/uL 0.0 - 11.25 mg/dL Negative 11.25 - 26.25 mg/dL Trace Protein 30 mg/dL 26.25 - 65 mg/dL 100 mg/dL 65 - 200 mg/dL 300 mg/dL > 200 mg/dL Negative 0.0 - 0.075 mg/dL Nitrite > 0.075 mg/dL Positive Negative 0.0 – 11.25 ca cells/uL Trace 11.25 – 56.25 ca cells/uL Leukocyte Small 56.25 – 111.25 ca cells/µL
Table: Measuring Range of Each Color Block of URS-10 Strips
111.25 - 406.25 ca cells/uL
Moderate
{16}------------------------------------------------
Image /page/16/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
| Large | > 406.25 ca cells/µL | |
|---|---|---|
| Urobilinogen | 0.2 mg/dL | 0.2 – 0.6 mg/dL |
| 1.0 mg/dL | 0.6 – 1.5 mg/dL | |
| 2.0 mg/dL | 1.5 – 3.0 mg/dL | |
| 4.0 mg/dL | 3.0 – 6.0 mg/dL | |
| 8.0 mg/dL | > 6.0 mg/dL | |
| pH | 5.0 | |
| 6.0 | 6.0 | |
| 6.5 | 6.5 | |
| 7.0 | 7.0 | |
| 7.5 | 7.5 | |
| 8.0 | 8.0 | |
| 8.5 | 8.5 | |
| SG | 1.005 | 1.005 |
| 1.010 | 1.010 | |
| 1.015 | 1.015 | |
| 1.020 | 1.020 | |
| 1.025 | 1.025 | |
| 1.030 | 1.030 |
C. Traceability and Stability:
Traceability and Expected Value:
Three levels of commercial urine controls that represent values as negative, low and high for all 10 URS parameters were used to assess the quality, the integrity and the stability of URS-10 strips during the manufacturing process and the storage of the strips. The package insert and certificate of analysis of these control solutions confirmed the specific target analyte concentration in each level. These controls were purchased from a commercially available supplier (HYCOR Biomedical), who sells their controls for standard testing throughout the world.
The expected ranges for all controls used for testing URS-10 strips are listed in the following table. Please see Appendix 18.D for the control details.
| Analyte | Level I | Level II | Level III |
|---|---|---|---|
| Glucose | $500 - \ge 1000$ mg/dL | 100 – 500 mg/dL | Negative |
| Bilirubin | Moderate to Large | Small to Moderate | Negative |
Table I: Urine Control Acceptable Range
{17}------------------------------------------------
Image /page/17/Picture/0 description: The image contains the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in a sans-serif font.
1268 N. Lakeview Ave., Anaheim, CA 92807, U.S.A. Phone: (714) 463-1111 Toll Free: 1-800-222-9880 Fax: (714) 463-1169 www.tecodiagnostics.com
| Ketone | $40 - \ge 80$ mg/dL | Trace - 40 mg/dL | Negative |
|---|---|---|---|
| Specific Gravity | 1.010 - 1.030 | $\le 1.005$ - 1.020 | $\le 1.005$ - 1.015 |
| Blood | Moderate to Large | Trace to Moderate | Negative |
| Nitrite | Positive | Positive | Negative |
| Protein | $100 - \ge 300$ mg/dL | Negative to 30 mg/dL | Negative |
| Urobilinogen | $4.0 - \ge 8.0$ EU/dL | 0.2 - 1.0 EU/dL | 0.2 - 1.0 EU/dL |
| Leukocyte | Small to Large | Trace to Moderate | Negative |
| pH | 7.0 - 8.5 | 7.0 - 8.5 | 5.0 - 7.0 |
510(k) SUMMARY
Stability:
Although the Teco Diagnostics URS-10 strips (K970250) have already passed all the Stability studies and approved by FDA for commercial use but we are performing three types of stability studies to assess the stability of URS-10 reagent strips with our new Uritek TC-201 urine analyzer.
(1) Open bottle study:
To monitor URS-10 strip's integrity after the strip bottle has been opened for use, open bottle study was conducted. This study involves testing URS-10 strips once periodically on TC-201 device, for 13 weeks using commercial urine controls levels I, II and III. Three (3) lots of URS-10 strip bottles used in the Open-vial Study will have passed Quality Control inspection and are opened (seals broken) and stored at room temperature (15-30°C) and 20-30% humidity. The acceptance criteria was that the tested strips must read all controls within the expected ranges as listed in the package insert for ≥ 90 days (pass 13 weeks) to confirm the statement "Do not use after 90 days of breaking the foil" on the URS-10 strip bottle label.
(2) Accelerated stability study:
Besides being used for testing product's integrity, accelerated stability study is often carried out to assess the shelf-life of a new product, which is verified in real-time studies. Accelerated stability study involves testing URS-10 strips once per week periodically on TC-201 device, for 13 weeks using commercial urine controls levels I, II and III. Three (3) lots of URS-10 strip bottles used in the Accelerated stability study will have passed Quality Control inspection and are sealed and stored at 37 C ± 2 C oven and 20-30% humidity. The acceptance criteria was that the tested strips must read all controls within the expected ranges as listed in Table 18.3.1 for > 90 days (pass 13 weeks) to confirm the sealed URS-10 strips bottle shelf life of two (2) years at room temperature (15-30°C) with 20-30% humidity.
(3) Real-time shelf-life study:
A real time, temperature and humidity stability study is currently being performed on sealed bottles of URS-10 strips to validate the claims stated in the Accelerated Stability Studies. This
{18}------------------------------------------------
Image /page/18/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
study involves testing the URS-10 strips on TC-201 device using commercial urine control levels I, II and III for every six (6) months from the manufactured date, until 18 months. After the URS-10 strips has passed 18 months, test every three (3) months until the product fails or until 27 months (3 months after the stated expiration date). Three (3) lots of URS-10 strips used in the Real Time Shelf Life Study will have passed Quality Control inspection and are sealed and stored at room temperature (15-30℃) and 20-30% humidity. The current strip label has an expiration date of 2 years.
The acceptance criteria was that the tested strips must read all controls within the expected ranges as listed in the package insert in real-time through its expiration date in the conditions that the product will be stored: sealed bottle, room temperature (15-30℃)
Results of all the stability studies are summarized in the following table. Please see Appendix 18.E Stability Study Data for data table.
| URS-10Strip Lot no. | Urine ControlLevel | Stability Study | ||
|---|---|---|---|---|
| Open Bottle | Accelerated stability | Real time Shelf Life | ||
| 63726 | Level I | Pass | Pass | Ongoing study |
| Level II | Pass | Pass | Ongoing study | |
| Level III | Pass | Pass | Ongoing study | |
| 63886 | Level I | Pass | Pass | Ongoing study |
| Level II | Pass | Pass | Ongoing study | |
| Level III | Pass | Pass | Ongoing study | |
| 64020 | Level I | Pass | Pass | Ongoing study |
| Level II | Pass | Pass | Ongoing study | |
| Level III | Pass | Pass | Ongoing study |
Table: Stability Study Test Results
D. Detection Limit
Sensitivity Study was performed to determine the cutoff point concentration at which each analyte on the URS-10 strip changed from negative to the positive color blocks. Samples were prepared by spiking the specified analyte concentration into negative urine with a minimum of 4 levels across the measuring range for each color block. Each pool was then analyzed in replicates of 8 by 3 operators on each of the 3 individual strip lots (8 strips x 3 operators/ strip lots), for a total of 24 data points for each level. The cutoff point determination study for each color block for each analyte is defined as the lowest concentration at which >55% of the test results are positive.
{19}------------------------------------------------
Image /page/19/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
1268 N. Lakeview Ave., Anaheim, CA 92807, U.S.A. Phone: (714) 463-1111 Toll Free: 1-800-222-9880 Fax: (714) 463-1169 www.tecodiagnostics.com
510(k) SUMMARY
The cut-off values and percentage sensitivity for each color block for individual analyte is summarized and demonstrated in the table below:
| Analyte | Color Block | Cut-off | % Positive Results |
|---|---|---|---|
| Glucose | 100 mg/dL | 75 mg/dL | 67% |
| 250 mg/dL | 212.5 mg/dL | 83% | |
| 500 mg/dL | 437.5 mg/dL | 83% | |
| 1000 mg/dL | 875 mg/dL | 75% | |
| Bilirubin | Small | 0.5 mg/dL | 59% |
| Moderate | 1.75 mg/dL | 87.5% | |
| Large | 3.0 mg/dL | 62.5% | |
| Ketone | Trace | 3.75 mg/dL | 71% |
| 15 mg/dL | 10 mg/dL | 71% | |
| 40 mg/dL | 27.5 mg/dL | 91% | |
| 80 mg/dL | 60 mg/dL | 75% | |
| Blood | Trace | 7.5 Ery/μL | 71% |
| Small | 21.25 Ery/μL | 75% | |
| Moderate | 52.5 Ery/μL | 67% | |
| Large | 170 Ery/μL | 71% | |
| Protein | Trace | 11.25 mg/dL | 91% |
| 30 mg/dL | 26.25 mg/dL | 75% | |
| 100 mg/dL | 65 mg/dL | 87% | |
| 300 mg/dL | 200 mg/dL | 87% | |
| Nitrite | Positive | 0.075 mg/dL | 58% |
| Leukocyte | Trace | 11.25 ca cells/µL | 58% |
| Small | 56.25 ca cells/µL | 67% | |
| Moderate | 111.25 ca cells/µL | 58% | |
| Large | 312.5 ca cells/µL | 67% | |
| Urobilinogen | 0.2 mg/dL | 0.2 mg/dL | 100% |
| 1.0 mg/dL | 0.8 mg/dL | 71% | |
| 2.0 mg/dL | 2.0 mg/dL | 90% | |
| 4.0 mg/dL | 3.5 mg/dL | 55% | |
| 8.0 mg/dL | 7.0 mg/dL | 85% | |
| pH | 5.0 | 5.0 | 96% |
| 6.0 | 6.0 | 100% | |
| 6.5 | 6.5 | 96% | |
| 7.0 | 7.0 | 96% | |
| 7.5 | 7.5 | 96% | |
| 8.0 | 8.0 | 96% | |
| 8.5 | 8.5 | 96% | |
| SG | 1.005 | 1.005 | 92% |
| 1.010 | 1.010 | 92% | |
| 1.015 | 1.015 | 92% | |
| 1.020 | 1.020 | 92% | |
| 1.025 | 1.025 | 92% | |
| 1.030 | 1.030 | 92% |
{20}------------------------------------------------
Image /page/20/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
E. Analytical Specificity
Endogenous and Exogenous Interference Study:
Potential endogenous interferents and drugs commonly found in urine were evaluated to assess the interfering effect of various substances on the performance of URS-10 strips on Uritek TC-201 Urine Analyzer. At least 2 levels of the listed interferents were added to the urine sample pools which were prepared at 3 concentrations for each urine chemistry analyte; negative, low positive and high positive. Each urine sample was tested with 3 replicates using Uritek TC-201 Urine Analyzer. Interference was defined as a change in output of ± 1 color blocks between spiked and unspiked control sample for all the URS parameters.
The concentrations of the potential interfering substances that did not have any influence on the test results are listed below:
| Potential Interfering Substance | Highest Concentration of substance testedwhich demonstrated no Interference |
|---|---|
| Ascorbic Acid | 30 mg/dL |
| Ammonium Chloride | 200 mg/dL |
| Albumin | ≤125 mg/dL |
| Bilirubin | 8 mg/dL |
| Creatine | 10 mg/dL |
| Lithium Acetoacetate | ≤60 mg/dL |
| Calcium Chloride | 100 mg/dL |
| Citric Acid | 50 mg/dL |
| Creatinine | 200 mg/dL |
| D (+) Glucose | 1500 mg/dL |
| Glycine | 450 mg/dL |
| Hemoglobin | 10 mg/dL |
| Potassium Chloride | 1500 mg/dL |
| Sodium Chloride | 4000 mg/dL |
| Oxalic Acid | 35 mg/dL |
| Sodium Acetate | 25 mg/dL |
| Sodium Nitrate | 10 mg/dL |
{21}------------------------------------------------
Image /page/21/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
| Sodium Nitrite | 10 mg/dL |
|---|---|
| Sodium Phosphate | 500 mg/dL |
| Uric Acid | 150 mg/dL |
| Urea | 4000 mg/dL |
| Riboflavin | 10 mg/L |
| Theophylline | 100 mg/L |
| D (+) Galactose | 80 mg/dL |
| Fructose | 100 mg/dL |
| Lactose | 10 mg/dL |
| Leucocytes | 3000 cells/uL |
| Blood | <0.01% |
| Human Immunoglobulins | 25 mg/dL |
| Formalin | 92.5 mg/dL |
| Amoxicillin | 30 mg/dL |
| Nitrofurantoin | 60 mg/dL |
| Gentamicin sulfate | 6 mg/dL |
| Acetaminophen | 40 mg/dL |
The following table shows the substances which did interfere with one or more of the Teco Diagnostics URS-10 analytes. Results are expressed as the lowest concentration of interfering substance that exhibited interference and the resulting change in output of color block.
| Analyte | Concentration of Substance at which Interference wasobserved | Change inColor blockOutput |
|---|---|---|
| Glucose | Blood (≥ 5%), Hypochlorite (≥ 0.6%), Pyridium (≥ 50 mg/dL) | +1, |
| Ascorbic Acid (≥ 75 mg/dL), Amoxicillin (≥ 100 mg/dL),Acetylcysteine (≥ 135 mg/dL) | -1 | |
| Protein | Hemoglobin (≥ 20 mg/dL), Blood (≥ 1%), Sodium | +1, +2 to +3, |
| Bicarbonate (1500 mg/dL), Chloroquine (≥ 20 mg/dL), | +1 to +2, +1 | |
| Pyridium (≥ 50 mg/dL), pH (> 8.5) | ||
| Amoxicillin (≥ 100 mg/dL), Hypochlorite (≥ 0.6%), | -1 | |
| SG (> 1.030) | ||
| Bilirubin | Blood (≥ 5%), Pyridium (≥ 50 mg/dL) | +2 to +3 |
| Formalin (≥ 185 mg/dL), Boric Acid (≥ 500 mg/dL), | -1 | |
| Acetylcysteine (≥ 67.5 mg/dL), Hypochlorite (≥ 0.6%) | ||
| Urobilinogen | Blood (≥ 1%) | +1 |
| Hypochlorite (≥ 0.6%) | -2 | |
| SG | Albumin (≥ 200 mg/dL), Blood (≥ 1%) | +1 |
{22}------------------------------------------------
Image /page/22/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in a sans-serif font.
| Nitrofurantoin (≥ 120 mg/dL) | -1 to -2 | |
|---|---|---|
| pH | SG (> 1.030), Sodium Bicarbonate (≥ 750 mg/dL), SodiumPhosphate (≥ 250 mg/dL), Creatinine (≥ 400 mg/dL) | +1 to +2 |
| Ascorbic Acid (≥75 mg/dL), Calcium Chloride (≥ 275 mg/dL)Citric Acid (≥ 75 mg/dL), Sodium Chloride (≥ 6000 mg/dL),Oxalic Acid (≥ 70 mg/dL) | -1 to -2 | |
| Blood | Albumin (200 mg/dL), Hypochlorite (≥ 0.6%) | +2 |
| Acetylcysteine (≥ 67.5 mg/dL) | -1 | |
| Nitrite | Blood (≥ 1%), Hypochlorite (≥ 0.6%), Pyridium (≥ 50 mg/dL) | +1 |
| Leukocytes | Blood (≥ 1%), Pyridium (≥ 50 mg/dL) | +1 to +2, |
| Glucose (≥ 2000 mg/dL), Boric Acid (≥ 500 mg/dL),Chloroquine (≥ 20 mg/dL), Amoxicillin (≥ 100 mg/dL),Hypochlorite (≥ 0.6%) | -1,-1 to -2 | |
| Ketone | Blood (≥ 5%), Acetylcysteine (≥ 67.5 mg/dL), Pyridium (≥ 50mg/dL) | +1, +2 to +3 |
| Hypochlorite (≥ 0.6%) | -1 to -2 |
pH Interference Study:
The sponsor performed an additional study to evaluate the effect of sample pH on the test results for the ten analytes in human urine. The study result shows that sample pH from 5.0 to 9.0 does not affect the test results for leukocytes, urobilinogen, ketone, pH, blood, nitrite, bilirubin and glucose. Samples with pH greater than 8.5 affected the protein test resulting in a false high result.
Specific Gravity Interference Study:
The sponsor performed an additional study to evaluate the effect of sample specific gravity on the test results for the ten analytes in human urine. The study result shows that sample specific gravity from 1.000 to 1.040 does not affect the test results for leukocytes, urobilinogen, ketone, blood, nitrite, bilirubin and glucose. Samples with specific gravity greater than 1.030 affected the pH and protein tests resulting in a false low result.
Based on the results of this testing the sponsor has included the effects from above interfering substances in the labeling as limitations of procedure.
F. Flex Study
Temperature and Humidity Study:
The environmental effect on the performance of Uritek TC-201 Urine Analyzer and URS-10 strips was evaluated by placing the strips in relative humidity of <20%, 30%, 60% and 70% environment at 15 C and 45 C. Strips were removed at 0.5h, 1h, 2h, 4h, 8h, 16h and 24h for testing using commercially available urine control solutions at Level I (High analyte concentration), Level II (Low analyte concentration) and Level III (Negative).
{23}------------------------------------------------
Image /page/23/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
Teco Diagnostics URS-10 strips were stable up to 70% humidity for over 24h at either 15 C or 45 C. 3 replicates of strips tested passed each control level at 100% exact match. Please see Appendix 18.H Humidity Study Data for data tables.
Timing Flex Study:
The effect of various dipping time in urine samples was evaluated for the performance of the Teco Diagnostics URS-10 strip. The strip was dipped in the urine samples for 1 second, 5 seconds and 10 seconds before removed for testing using commercially available urine control solutions at Level I (High analyte concentration), Level II (Low analyte concentration) and Level III (Negative). Results showed that the dipping time had no interfering effect on the test. Please see Appendix 18.I Timing Flex Study Data for data tables.
Sample Running Over Study:
The interference of samples running over from one pad to the adjacent pad on the performance of URS-10 strip was evaluated. The strip was dipped into a urine sample and upon removal, was held upward to allow the sample flow from the leukocyte pad to the next aligned pads or held downward to allow the sample flow from the glucose pad to the next aligned pads before testing. Commercially available urine control solutions at Level I (High analyte concentration), Level II (Low analyte concentration) and Level III (Negative) were used for testing. Results demonstrate that sample running over from one test pad had no interfering effect on the test of the other pad. Please see Appendix 18.J Sample Running Over Study Data for data tables.
Analyzer Operating Conditions Study:
All the performance testing (linearity, sensitivity and interference) was carried out at ideal laboratory conditions 15-20 C and 15-30% Relative Humidity.
An additional study was performed to ensure the claim of acceptable operating conditions at 15-30 C and 18-80% Relative Humidity for the Uritek TC-201 Urine Analyzer. The performance of Uritek TC-201 Urine Analyzer and URS-10 strips was evaluated by placing the Uritek TC-201 Urine analyzer in relative humidity of >80% environment at ≥30 C. These conditions were manufactured artificially in the Laminar Air Flow Cabinet by placing Hot Water Steam Bath and a Humidifier. Tests were performed at particular time-points at 0.1h. 8h. 16h and 24h using commercially available urine control solutions at Level I (High analyte concentration), Level II (Low analyte concentration) and Level III (Negative).
Uritek TC-201 Urine Analyzer was stable at 92% humidity for over 24h at 30 C. The acceptance criteria was that the tested strips must read all controls within the expected ranges as listed in Table 18.3.1. 5 replicates of strips tested passed for each control level. Please see Appendix 18.M Analyzer Operating Conditions Study Data for data tables.
{24}------------------------------------------------
Image /page/24/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
4. Comparison Study
A. Method Comparison with Predicate Device:
Three Point-of-Care (POC) Sites that represented the intended user sites of these devices were selected to perform the method comparison studies to evaluate the performance of the Teco Diagnostics Urinalysis Reagent Strip (URS-10) read by the Uritek TC-201 Urine Analyzer compared to the performance of the predicate method, Siemens Multistix 10 SG Reagent strip read by Siemens Clinitek Status+ Urine Analyzer. Each site randomly selected at least 115, unaltered patient samples to test on both device pairings. In order to evaluate the performance of the candidate device over the entire measuring range of each analyte, additional contrived samples (10% of the total samples) were tested resulting in up to 392 specimens evaluated at all sites. Three lots of Teco Diagnostics Urinalysis Reagent Strip (URS-10) and 3 units of Uritek TC-201 Urine Analyzer were used in the study (detailed information is provided in Appendix 18.L). Three operators at each site ran the samples.
An additional method comparison study was performed at POC Site I and Site II for a total of 91 clinical samples to demonstrate the substantial equivalence accuracy for all the URS parameters. Moreover a separate study was performed at Site I wherein the patient urine samples were prescreened at pH ≥ 8.0 using a standardized pH meter and then performed the method comparison study using Uritek TC-201 Urine Analyzer and Siemens Clinitek Status+ Urine Analyzer. The total number of patient urine specimens evaluated in the Method Comparison Study is 509. (392+91+26) Gender and unique patient identifiers were recorded for each sample tested. Testing results are summarized in the following tables.
| Glucose | Siemens Clinitek Status + Urine Analyzer | ||||||
|---|---|---|---|---|---|---|---|
| 3 Sites, N=509 | 1000 | 500 | 250 | 100 | Neg | Overall | |
| 1000 | 16 | 4 | 0 | 0 | 0 | 20 | |
| Uritek TC- | 500 | 4 | 37 | 0 | 0 | 0 | 41 |
| 201 Urine | 250 | 0 | 0 | 10 | 0 | 0 | 10 |
| Analyzer | 100 | 0 | 0 | 0 | 25 | 0 | 25 |
| Neg | 0 | 0 | 0 | 0 | 0 | 413 | 413 |
| Total | 20 | 41 | 10 | 25 | 413 | 509 | |
| Agreement within same | 80.00% | 90.24% | 100.0% | 100.0% | 100.0% | 98.43% | |
| color block (Exact Match) | (16/20) | (37/41) | (10/10) | (25/25) | (413/413) | (501/509) | |
| Agreement within ±1 color | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| block | (20/20) | (37/41) | (10/10) | (25/25) | (413/413) | (509/509) |
Glucose concentration levels compared at a 98.43% overall exact match and a 100.0% overall agreement ±1 color block match between the Uritek TC-201 Urine Analyzer and Siemens Clinitek Status+ Analyzer.
{25}------------------------------------------------
Image /page/25/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside. To the right of the hexagon is the text "Teco Diagnostics" in a sans-serif font.
| Bilirubin | Siemens Clinitek Status + Urine Analyzer | |||||
|---|---|---|---|---|---|---|
| 3 Sites, N=509 | 3+ | 2+ | 1+ | Neg | Overall | |
| Uritek TC-201 UrineAnalyzer | 3+ | 35 | 1 | 0 | 0 | 36 |
| 2+ | 0 | 31 | 0 | 0 | 31 | |
| 1+ | 0 | 0 | 51 | 5 | 56 | |
| Neg | 0 | 0 | 0 | 386 | 386 | |
| Total | 35 | 32 | 51 | 391 | 509 | |
| Agreement within samecolor block (Exact Match) | 100.0%(35/35) | 96.88%(31/32) | 100.0%(51/51) | 98.72%(386/391) | 98.82%(503/509) | |
| Agreement within ±1 colorblock | 100.0%(35/35) | 100.0%(32/32) | 100.0%(51/51) | 100.0%(391/391) | 100.0%(509/509) |
Bilirubin concentration levels compared at a 98.82% overall exact match and a 100.0% overall agreement ±1 color block match between the Uritek TC-201 Urine Analyzer and Siemens Clinitek Status+ Analyzer.
| Ketone | Siemens Clinitek Status + Urine Analyzer | ||||||
|---|---|---|---|---|---|---|---|
| 3 Sites, N=509 | 80 | 40 | 15 | Trace | Neg | Overall | |
| 80 | 13 | 1 | 0 | 0 | 0 | 14 | |
| Uritek TC- | 40 | 0 | 18 | 1 | 0 | 0 | 19 |
| 201 UrineAnalyzer | 15 | 0 | 0 | 24 | 1 | 0 | 25 |
| TRA | 0 | 0 | 0 | 44 | 4 | 48 | |
| Neg | 0 | 0 | 0 | 1 | 402 | 403 | |
| Total | 13 | 19 | 25 | 46 | 406 | 509 | |
| Agreement within samecolor block (Exact Match) | 100.0%(13/13) | 94.74%(18/19) | 96.0%(24/25) | 95.65%(44/46) | 99.01%(402/406) | 98.43%(501/509) | |
| Agreement within ±1 colorblock | 100.0%(13/13) | 100.0%(19/19) | 100.0%(25/25) | 100.0%(46/46) | 100.0%(406/406) | 100.0%(509/509) |
Ketone concentration levels compared at a 98.43% overall exact match and a 100.0% overall agreement ±1 color block match between the Uritek TC-201 Urine Analyzer and Siemens Clinitek Status+ Analyzer.
{26}------------------------------------------------
Image /page/26/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
| Specific Gravity | Siemens Clinitek Status + Urine Analyzer | |||||||
|---|---|---|---|---|---|---|---|---|
| 3 Sites, N=509 | ≥1.030 | 1.025 | 1.020 | 1.015 | 1.010 | <1.005 | Overall | |
| Uritek TC-201 UrineAnalyzer | >1.030 | 57 | 5 | 0 | 0 | 0 | 0 | 62 |
| 1.025 | 6 | 55 | 5 | 0 | 0 | 0 | 66 | |
| 1.020 | 0 | 21 | 112 | 10 | 0 | 0 | 143 | |
| 1.015 | 0 | 0 | 16 | 135 | 6 | 0 | 157 | |
| 1.010 | 0 | 0 | 0 | 8 | 40 | 7 | 55 | |
| <1.005 | 0 | 0 | 0 | 0 | 4 | 22 | 26 | |
| Total | 63 | 81 | 133 | 153 | 50 | 29 | 509 | |
| Agreement within same | ||||||||
| color block (ExactMatch) | 90.48%(57/63) | 67.90%(55/81) | 84.21%(112/133) | 88.24%(135/153) | 80.0%(40/50) | 75.86%(22/29) | 82.71%(421/509) | |
| Agreement within ±1color block | 100.0%(63/63) | 100.0%(81/81) | 100.0%(133/133) | 100.0%(153/153) | 100.0%(50/50) | 100.0%(29/29) | 100.0%(509/509) |
Specific Gravity concentration levels compared at a 82.71% overall exact match and a 100.0% overall agreement ±1 color block match between the Uritek TC-201 Urine Analyzer and Siemens Clinitek Status+ Analyzer.
*The Acceptance Criteria for SG is +/- 0.005.
| Blood | Siemens Clinitek Status + Urine Analyzer | ||||||
|---|---|---|---|---|---|---|---|
| 3 Sites, N=509 | 3+ | 2+ | 1+ | Trace | Neg | Overall | |
| Uritek TC-201Urine Analyzer | 3+ | 32 | 3 | 0 | 0 | 0 | 35 |
| 2+ | 0 | 55 | 0 | 0 | 0 | 55 | |
| 1+ | 0 | 0 | 21 | 0 | 0 | 21 | |
| Trace | 0 | 0 | 1 | 63 | 2 | 66 | |
| Neg | 0 | 0 | 0 | 4 | 328 | 332 | |
| Total | 32 | 58 | 22 | 67 | 330 | 509 | |
| Agreement within samecolor block (Exact Match) | 100.0%(32/32) | 94.83%(55/58) | 95.45%(21/22) | 94.03%(63/67) | 99.39%(328/330) | 98.04%(499/509) | |
| Agreement within ±1 colorblock | 100.0%(32/32) | 100.0%(58/58) | 100.0%(22/22) | 100.0%(67/67) | 100.0%(330/330) | 100.0%(509/509) |
Blood concentration levels compared at a 98.04% overall exact match and a 100.0% overall agreement ±1 color block match between the Uritek TC-201 Urine Analyzer and Siemens Clinitek Status+ Analyzer.
{27}------------------------------------------------
Image /page/27/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
| Protein | Siemens Clinitek Status + Urine Analyzer | |||||||
|---|---|---|---|---|---|---|---|---|
| 3 Sites, N=509 | >300 | 100 | 30 | Trace | Neg | Overall | ||
| >300 | 26 | 0 | 0 | 0 | 0 | 26 | ||
| 100 | 0 | 35 | 0 | 0 | 0 | 35 | ||
| Uritek TC-201Urine Analyzer | 30 | 0 | 3 | 34 | 0 | 0 | 37 | |
| Trace | 0 | 0 | 2 | 46 | 6 | 54 | ||
| Neg | 0 | 0 | 0 | 3 | 354 | 357 | ||
| Total | 26 | 38 | 36 | 49 | 360 | 509 | ||
| Agreement within same | 100.0% | 92.11% | 94.44% | 93.88% | 98.33% | 97.25% | ||
| color block (Exact Match) | (26/26) | (35/38) | (34/36) | (46/49) | (354/360) | (495/509) | ||
| Agreement within ±1 color | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | ||
| block | (26/26) | (38/38) | (36/36) | (49/49) | (360/360) | (509/509) |
Protein concentration levels compared at a 97.25% overall exact match and a 100.0% overall agreement ±1 color block match between the Uritek TC-201 Urine Analyzer and Siemens Clinitek Status+ Analyzer.
| Urobilinogen | Siemens Clinitek Status + Urine Analyzer | ||||||
|---|---|---|---|---|---|---|---|
| 3 Sites, N=509 | >8.0 | 4 | 2 | 1 | 0.2 | Overall | |
| Uritek TC-201Urine Analyzer | >8.0 | 31 | 0 | 0 | 0 | 0 | 31 |
| 4.0 | 0 | 26 | 0 | 0 | 0 | 26 | |
| 2.0 | 0 | 0 | 22 | 0 | 0 | 22 | |
| 1.0 | 0 | 0 | 0 | 14 | 0 | 14 | |
| 0.2 | 0 | 0 | 0 | 2 | 414 | 416 | |
| Total | 31 | 26 | 22 | 16 | 414 | 509 | |
| Agreement within same colorblock (Exact Match) | 100.0%(31/31) | 100.0%(26/26) | 100.0%(22/22) | 87.5%(14/16) | 100.0%(414/414) | 99.61%(507/509) | |
| Agreement within ±1 colorblock | 100.0%(31/31) | 100.0%(26/26) | 100.0%(22/22) | 100.0%(16/16) | 100.0%(414/414) | 100.0%(509/509) |
Urobilinogen concentration levels compared at a 99.61% overall exact match and a 100.0% overall agreement ±1 color block match between the Uritek TC-201 Urine Analyzer and Siemens Clinitek Status+ Analyzer.
{28}------------------------------------------------
Image /page/28/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
| pH | Siemens Clinitek Status + Urine Analyzer | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3 Sites, N=509 | 8.5 | 8 | 7.5 | 7.0 | 6.5 | 6.0 | 5.0 | Overall | |
| Uritek | 8.5 | 36 | 0 | 0 | 0 | 0 | 0 | 0 | 36 |
| TC-201Urine | 8.0 | 2 | 15 | 5 | 0 | 0 | 0 | 0 | 22 |
| Analyzer | 7.5 | 1 | 1 | 34 | 1 | 0 | 0 | 0 | 37 |
| 7.0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 100 | |
| 6.5 | 0 | 0 | 0 | 8 | 65 | 1 | 0 | 74 | |
| 6.0 | 0 | 0 | 0 | 0 | 11 | 89 | 8 | 108 | |
| 5.0 | 0 | 0 | 0 | 0 | 1 | 9 | 122 | 132 | |
| Total | 39 | 16 | 39 | 109 | 77 | 99 | 130 | 509 | |
| Agreement withinsame color block(Exact Match) | 92.31%(36/39) | 93.75%(15/16) | 87.18%(34/39) | 91.74%(100/109) | 84.42%(65/77) | 89.90%(89/99) | 93.85%(122/130) | 90.57%(461/509) | |
| Agreement within±1 color block | 97.44%(38/39) | 100.0%(16/16) | 100.0%(39/39) | 100.0%(109/109) | 98.70%(76/77) | 100.0%(99/99) | 100.0%(130/130) | 99.61%(507/509) |
pH concentration levels compared at an 90.57% overall exact match and a 99.61% overall agreement ±1 color block match between the Uritek TC-201 Urine Analyzer and Siemens Clinitek Status+ Analyzer.
| Nitrite | Siemens Clinitek Status + Urine Analyzer | |||
|---|---|---|---|---|
| 3 Sites, N=509 | POS | NEG | Overall | |
| Uritek TC-201Urine Analyzer | POS | 80 | 2 | 82 |
| NEG | 1 | 426 | 427 | |
| Total | 81 | 428 | 509 | |
| Agreement within same colorblock (Exact Match) | 98.77%(80/81) | 99.53%(426/428) | 99.41%(506/509) | |
| Agreement within ±1 color block | N/A | N/A | N/A |
Nitrite concentration levels compared at a 99.41% overall exact match between the Uritek TC-201 Urine Analyzer and Siemens Clinitek Status+ Analyzer.
{29}------------------------------------------------
Image /page/29/Picture/0 description: The image shows the logo for "Teco Diagnostics". The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in a sans-serif font.
| Leukocyte | Siemens Clinitek Status + Urine Analyzer | ||||||
|---|---|---|---|---|---|---|---|
| 3 Sites, N=509 | 3+ | 2+ | 1+ | Trace | Neg | Overall | |
| 3+ | 39 | 0 | 0 | 0 | 0 | 39 | |
| 2+ | 0 | 12 | 0 | 0 | 0 | 12 | |
| Uritek TC-201Urine Analyzer | 1+ | 0 | 1 | 49 | 0 | 0 | 50 |
| Trace | 0 | 0 | 1 | 27 | 7 | 35 | |
| Neg | 0 | 0 | 0 | 2 | 371 | 373 | |
| Total | 39 | 13 | 50 | 29 | 378 | 509 | |
| Agreement within same color | 100.0% | 92.31% | 98.00% | 93.10% | 98.15% | 97.84% | |
| block (Exact Match) | (39/39) | (12/13) | (49/50) | (27/29) | (371/378) | (498/509) | |
| Agreement within ±1 color | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| block | (39/39) | (12/13) | (50/50) | (29/29) | (378/378) | (509/509) |
Leukocyte concentration levels compared at a 97.84% overall exact match and a 100% overall agreement ±1 color block match between the Uritek TC-201 Urine Analyzer and Siemens Clinitek Status+ Analyzer.
B. Matrix Comparison:
Not applicable.
5. Clinical Study:
Not applicable.
6. Expected Values/Reference Range:
Glucose: Small amounts of glucose are normally excreted by the kidney. J Concentrations as little as 0.1 g/dl glucose, read either at 10 or 30 seconds, may be significantly abnormal if found consistently. At 10 seconds, results should be interpreted qualitatively; for semi-quantitative results, read at 30 seconds only.
Bilirubin: Normally, no bilirubin is detectable in urine by even the most sensitive method. Even trace amounts of bilirubin are sufficiently abnormal to require further investigation. Atypical colors (colors produced which are different than the negative or positive color blocks shown on the Color Chart) may indicate that bilirubin derived bile pigments are present in the urine sample and are possibly masking the bilirubin reaction.
{30}------------------------------------------------
Image /page/30/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
Ketone: Normally, no ketones are present in urine. Detectable levels of ketone may occur in urine during physiological stress conditions such as fasting, pregnancy, and frequent strenuous exercise. In starvation diets, or in other abnormal carbohydrate metabolism situation, ketones appear in the urine in excessively large amounts before serum ketones are elevated.
Specific Gravity: Random urine may vary in specific gravity from 1.003-1.040+. Twenty-four hour urine from normal adults with normal diets and normal fluid intake will have a specific gravity of 1.016-1.022.10
Blood: Any green spots or green color developing on the reagent area within 40 seconds is significant and the urine should be examined further. Blood is frequently, but not invariably found in the urine of menstruating females.
pH: The normal pH of urine can range from 4.5-8.0. The average pH values in healthy subjects is 6.0.3
Protein: In 24-hour urine, 1-14 mg/d of protein may be excreted by the normal kidney. A color matching any color block greater than trace indicates significant proteinuria. For urine with high specific gravity, the test area may most closely match the trace color block even though only normal concentrations of protein are present. Clinical judgment is needed to evaluate the significance of trace results.
Urobilinogen: In a healthy population, the normal urine urobilinogen range obtained with this test is 0.2-1.0 Ehrlich Unit/dL. A result of 2.0 EU/dL may be of clinical significance and the same patient sample should be evaluated further.
Nitrite: Normally no detectable amount of nitrite is present in urine. 3 The nitrite area will be positive in a proportion of cases of significant infection, depending on how long the urine specimens were retained in the bladder prior to collection. Retrieval of positive cases with the nitrite test range from as low as 40%, in instances where little bladder incubation occurred, to as high as 80% in instances where a minimum of 4 hours incubation occurred.
Leukocytes: Normal urine specimens generally yield negative results with this test. A trace result may be of questionable clinical significance and it is recommended that the test be repeated using a fresh sample from the same patient. Repeated trace and positive results are of clinical significance.
{31}------------------------------------------------
Image /page/31/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside of it. To the right of the hexagon is the text "Teco Diagnostics" in black.
References:
-
- Free, A.H and Free, H.M .: Urinalysis, Critical Discipline of Clinical Science. CRC Crit. Rev. Clin. Lab. Sci. 3(4): 481-531; (1972).
-
- Yoder, J.Adams, E.C., and Free. H.M .: Simultaneous Screening for Urinary Occult Blood, Protein, Glucose and pH. Amer. J. Med Tech. 31:285; (1965).
-
- Tietz, N.W .: Clinical Guide to Laboratory Tests; W.B. Saunders Company, (1976).
-
- Burtis, C.A. and Ashwood, E.R .: Tietz Textbook of Clinical Chemistry 200 Ed. 2205; (1994).
-
- Schersten, B. and Fritz, H.: Subnormal Levels of Glucose in Urine. JAMA 201:129-132; (1967).
-
- McGarry, J.D .: Lilly Lecture, 1978: New Perspectives in the Regulation of Ketogenesis. Diabetes 28: 517-523 May, (1978).
-
- Williamson, D.H.: Physiological ketoses, or Why Ketone Bodies? Postgrad. Med. J. (June Suppl.): 371-375: (1971).
-
- Paterson, P. et al.: Maternal and Fetal Ketone Concentrations in Plasma and Urine. Lancet: 862-865; April 22, (1967).
-
- Fraser, J. et al .: Studies with a Simplified Nitroprusside Test for Ketone Bodies in Urine, Serum, Plasma and Milk. Clin. Chem. Acta II: 372-378; (1965).
-
- Henry, J.B. et al .: Clinical Diagnosis and Management by Laboratory Methods, 17" Ed. Philadelphia: Saunders; (1979).
-
- Beer JH, Vogt A, Neftel K, et al. False positive results for leucocytes in urine dipstick test with common antibiotics. BMJ 313:25; (1996).
-
- Csako G. False positive results for ketone with the drug MESNA and other freesulfhydryl compounds, Clin Chem. (1987).
-
- Young, D.S., et al.: Effects of Drugs on Clinical Laboratory Tests. Clin. Chem. Vol. 18 (10): 1041-1303; 1972.
{32}------------------------------------------------
Image /page/32/Picture/0 description: The image shows the logo for Teco Diagnostics. The logo consists of a green hexagon with the letters "TC" in white inside. To the right of the hexagon is the text "Teco Diagnostics" in black font.
IX. Conclusion:
Device verification and validation testing confirms that product specifications are met, which supports the intended use and technological characteristic as the predicate devices. The information provided supports the substantial equivalence to the predicate device and that the system is safe and effective for the users/operators.
The performance characteristics of the Uritek TC-201 Urine Analyzer with the Urine Reagent (URS-10) Strips were verified by were verified by precision study, linearity study, traceability study, stability study, detection limit study, specificity study, and flex study. Testing results indicate that the Uritek TC-201 Urine Analyzer and Urine Reagent (URS-10) Strips perform satisfactorily when used appropriately, as outlined in the package insert.
Method comparison study results demonstrate a substantial equivalency on performance between Uritek TC-201 with Urine Reagent (URS-10) Strips and the predicate device, Clinitek Status Plus Urine Analyzer with Clinitek Multistix 10 SG Strips. In summary, the results present here support the substantial equivalence to the predicate device.
§ 862.1340 Urinary glucose (nonquantitative) test system.
(a)
Identification. A urinary glucose (nonquantitative) test system is a device intended to measure glucosuria (glucose in urine). Urinary glucose (nonquantitative) measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, hypoglycemia, and hyperglycemia.(b)
Classification. Class II.